CN112724242B - Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris - Google Patents
Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris Download PDFInfo
- Publication number
- CN112724242B CN112724242B CN202011630131.XA CN202011630131A CN112724242B CN 112724242 B CN112724242 B CN 112724242B CN 202011630131 A CN202011630131 A CN 202011630131A CN 112724242 B CN112724242 B CN 112724242B
- Authority
- CN
- China
- Prior art keywords
- pichia pastoris
- protein
- collagen
- recombinant human
- host cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 59
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 59
- 102000008186 Collagen Human genes 0.000 title claims abstract description 45
- 108010035532 Collagen Proteins 0.000 title claims abstract description 45
- 229920001436 collagen Polymers 0.000 title claims abstract description 45
- 241000235058 Komagataella pastoris Species 0.000 title claims abstract description 39
- 238000004519 manufacturing process Methods 0.000 title abstract description 8
- 238000000855 fermentation Methods 0.000 claims abstract description 41
- 230000004151 fermentation Effects 0.000 claims abstract description 41
- 238000000108 ultra-filtration Methods 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 22
- 238000004255 ion exchange chromatography Methods 0.000 claims abstract description 18
- 241000235648 Pichia Species 0.000 claims abstract description 14
- 238000010612 desalination reaction Methods 0.000 claims abstract description 11
- 238000001914 filtration Methods 0.000 claims abstract description 5
- 230000001954 sterilising effect Effects 0.000 claims abstract description 4
- 235000018102 proteins Nutrition 0.000 claims description 56
- 239000000243 solution Substances 0.000 claims description 19
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 claims description 18
- 239000008055 phosphate buffer solution Substances 0.000 claims description 10
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 9
- 239000011780 sodium chloride Substances 0.000 claims description 9
- 239000003480 eluent Substances 0.000 claims description 8
- 239000012528 membrane Substances 0.000 claims description 7
- 239000011550 stock solution Substances 0.000 claims description 7
- 238000011084 recovery Methods 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- 238000011068 loading method Methods 0.000 claims description 5
- 238000001742 protein purification Methods 0.000 claims description 5
- 239000006228 supernatant Substances 0.000 claims description 5
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 claims description 3
- 239000001963 growth medium Substances 0.000 claims description 3
- 239000012535 impurity Substances 0.000 claims description 3
- 238000005342 ion exchange Methods 0.000 claims description 3
- 238000002156 mixing Methods 0.000 claims description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 claims description 3
- 235000019799 monosodium phosphate Nutrition 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000000047 product Substances 0.000 claims description 3
- 239000012460 protein solution Substances 0.000 claims description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 claims description 3
- 238000009777 vacuum freeze-drying Methods 0.000 claims description 3
- 150000001768 cations Chemical class 0.000 claims description 2
- 238000012856 packing Methods 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 235000004252 protein component Nutrition 0.000 claims description 2
- 238000005406 washing Methods 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 12
- 230000008569 process Effects 0.000 abstract description 5
- 230000006698 induction Effects 0.000 abstract description 4
- 238000005119 centrifugation Methods 0.000 abstract description 3
- 238000004108 freeze drying Methods 0.000 abstract description 2
- 238000004659 sterilization and disinfection Methods 0.000 abstract description 2
- 238000000746 purification Methods 0.000 description 8
- 238000011031 large-scale manufacturing process Methods 0.000 description 4
- 239000000463 material Substances 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 238000011033 desalting Methods 0.000 description 3
- 239000012474 protein marker Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 241000894006 Bacteria Species 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000000706 filtrate Substances 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 239000008213 purified water Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002684 Sepharose Polymers 0.000 description 1
- 241001052560 Thallis Species 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 239000011543 agarose gel Substances 0.000 description 1
- 125000003275 alpha amino acid group Chemical group 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- OHJMTUPIZMNBFR-UHFFFAOYSA-N biuret Chemical compound NC(=O)NC(N)=O OHJMTUPIZMNBFR-UHFFFAOYSA-N 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000010828 elution Methods 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000012510 hollow fiber Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 231100000053 low toxicity Toxicity 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 238000009629 microbiological culture Methods 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000012264 purified product Substances 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000004064 recycling Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/78—Connective tissue peptides, e.g. collagen, elastin, laminin, fibronectin, vitronectin or cold insoluble globulin [CIG]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
- C12N15/815—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts for yeasts other than Saccharomyces
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Abstract
The invention discloses a method for producing recombinant human-like collagen and host cell protein by using Pichia pastoris, which comprises the steps of carrying out methanol induction on a strain Pichia pastoris-col3-6 in the fermentation culture process, and carrying out centrifugation, filtration sterilization, ultrafiltration desalination concentration, ion exchange chromatography, ultrafiltration desalination and freeze-drying on the obtained fermentation liquor to obtain the recombinant human-like collagen and target host protein.
Description
Technical Field
The invention belongs to the technical field of protein engineering, and particularly relates to a separation and purification method of recombinant human-like collagen and host cell protein expressed by pichia pastoris.
Background
Collagen is a protein with the largest content in the body, accounts for about 25-33% of the protein of the human body, is widely distributed in various tissues and organs of the human body, such as skin, bones, corneas, blood vessels and the like, particularly contains a large amount of collagen in the tissues such as the skin and the like, and has an important role in maintaining the normal physiological functions of cells, tissues and organs as an adhesive substance of connective tissues. The recombinant collagen has the advantages of low toxicity, low antigenicity, low immunity, cell regeneration guiding performance, good biocompatibility and the like, and is widely applied to the industries of biological medicines, cosmetics, foods and the like.
Protein Maker is made of a variety of purified proteins of known molecular weight and is widely used in biological experiments to monitor the migration of other proteins in gel electrophoresis and to identify the molecular weight of these proteins. Host cell protein expressed by pichia pastoris has stable property and can be used as a potential raw material of protein marker.
At present, the production cost of the recombinant human-like collagen expressed by pichia pastoris is higher due to the investment of equipment, personnel and production operation in the purification process. Meanwhile, host cell proteins expressed by pichia pastoris have not been effectively utilized in the production process (the reasons include that the content of host cell proteins in fermentation broth is limited, and they are generally treated as impurities in purification, for example, chinese patent CN 103102407A).
Disclosure of Invention
The invention aims to provide a method for producing recombinant human-like collagen and host cell protein by using pichia pastoris.
In order to realize the purpose, the invention adopts the following technical scheme:
a protein purification method of pichia pastoris fermentation liquor comprises the following steps:
separating and removing thallus cells in the pichia pastoris fermentation liquor, then carrying out ultrafiltration, and carrying out ion exchange chromatography on the ultrafiltration product to respectively obtain recombinant human-like collagen and host cell protein produced by pichia pastoris fermentation.
Preferably, the method for purifying the protein of the pichia pastoris fermentation broth specifically comprises the following steps:
1) centrifuging the fermentation liquor of the pichia pastoris, sequentially filtering and sterilizing supernatant obtained by centrifuging, ultrafiltering and desalting, and mixing concentrated solution containing the recombinant human collagen obtained by ultrafiltration and desalting with residual protein (components including host cell protein) recovery solution of an ultrafiltration system to obtain mixed feed liquid;
2) separating the recombinant human-like collagen and the host cell protein in the mixed feed liquid by ion exchange chromatography.
Preferably, the Pichia pastoris is selected from wild type or mutant Pichia pastoris (Pichia pastoris) genetically engineered bacteria.
Preferably, the Pichia pastoris is selected from a strain Pichia pastoris-col3-6 (belonging to genetically engineered bacteria), the preservation number of the strain is CGMCC No.20458, and protein components of a fermentation liquor produced by fermenting the strain comprise recombinant human-like collagen with the molecular weight of 91.3KD and host cell protein with the molecular weight of 65 KD.
Preferably, the preparation method of the pichia pastoris fermentation broth comprises the following steps: culturing pichia in a fermentation culture medium and carrying out induced expression of the recombinant human-like collagen to obtain pichia fermentation liquor.
Preferably, the preparation method of the pichia pastoris fermentation broth specifically comprises the following steps: culturing the pichia pastoris inoculated in the fermentation medium until a certain thallus density is reached, and performing methanol induction by replacing a carbon source of the fermentation medium with methanol in subsequent culture, wherein the culture conditions comprise: the pH value is 4.8-5.2, the temperature is 25-30 ℃, and the dissolved oxygen is controlled at 30%.
Preferably, the ultrafiltration desalination adopts a 6-15 KD ultrafiltration membrane, and the conductivity of the concentrated solution is lower than 1 ms/cm; the recovery liquid is obtained by recycling residual protein of the ultrafiltration system by using purified water.
Preferably, the ion exchange column packing used for the ion exchange chromatography is selected from weak cation exchangers taking agarose gel as a matrix.
Preferably, the step 2) specifically comprises the following steps: adjusting the pH value of the mixed feed liquid to 6.0-6.5 by using sodium hydroxide to obtain an ion exchange chromatography stock solution, and adjusting the pH value of the ion exchange chromatography stock solution to 6.0-6.5 by using disodium hydrogen phosphate and sodium dihydrogen phosphate to carry out sample loading; after the sample loading is finished, eluting host cell protein by using a phosphate buffer solution with the pH value of 6.0-6.5 and the concentration of 8-10 mmol/L containing 0.04-0.06 mol/L NaCl as an eluent, eluting by using a phosphate buffer solution with the pH value of 6.0-6.5 and the concentration of 8-10 mmol/L containing 0.08-0.1 mol/L NaCl as an eluent, and finally eluting the recombinant human-like collagen by using a phosphate buffer solution with the pH value of 6.0-6.5 and the concentration of 8-10 mmol/L containing 0.3-0.4 mol/L NaCl as an eluent.
Preferably, the method for purifying the protein of the pichia pastoris fermentation broth further comprises the following steps: after the step 2), respectively carrying out ultrafiltration desalination on the recombinant human-like collagen solution and the host cell protein solution obtained by elution by adopting 6-15 KD ultrafiltration membranes, and then carrying out vacuum freeze drying to obtain the recombinant human-like collagen and the host cell protein.
The invention has the following beneficial effects:
in the process of separating and purifying the recombinant human-like collagen in the pichia pastoris fermentation liquor, other process means are not added, so that high-purity host cell protein can be obtained simultaneously, the production cost of the recombinant human-like collagen is greatly reduced by the value generated by a byproduct (the host cell protein can be used as a protein Marker), and the method is suitable for industrial large-scale production. The invention solves the problem of high cost of industrial large-scale production of recombinant human-like collagen expressed by pichia pastoris while maintaining high yield, high yield and high purity of the recombinant human-like collagen produced by fermentation.
Furthermore, the Pichia pastoris strain Pichia pastoris-col3-6 adopted by the invention not only can stably ferment and produce the recombinant human-like collagen, but also can produce host cell protein with higher content in fermentation compared with other known Pichia strains.
Furthermore, the invention can reduce the conductivity of the concentrated solution and improve the stability and the separation efficiency of the recombinant human-like collagen and the host cell protein by controlling the molecular interception amount of the ultrafiltration membrane.
Furthermore, the invention can simultaneously obtain two high-purity proteins by further ion exchange chromatography, wherein the recovery rates of the recombinant human collagen and the host cell protein are both up to more than 70%, and the purity is both up to more than 95%. Meanwhile, the two proteins are completely decolorized by ion exchange chromatography, and the method is suitable for industrial large-scale production.
Furthermore, the liquid reagents used in the purification process of the invention are all prepared by inorganic salt, and have simple components and low cost.
Drawings
FIG. 1 is a structural design diagram of recombinant human-like collagen: the protein contains 1011 amino acids of protein sequence full length, theoretical Molecular Weight (MW) and isoelectric Point (PI).
FIG. 2 is a SDS-PAGE electrophoresis chart of a fermentation broth purified product of the strain Pichia pastoris-col 3-6; wherein, lane 1: protein Marker, lane 2: recombinant human collagen (115KD, electrophoretic characterization error leads to higher molecular weight in the electropherogram compared to theoretical molecular weight), lane 3: target host protein (65 kD).
Detailed Description
The present invention will be described in further detail with reference to the drawings and examples. The examples are given solely for the purpose of illustration and are not intended to limit the scope of the invention.
(I) fermentation strain acquisition
The invention obtains a Pichia pastoris strain (recorded as a strain Pichia pastoris-col3-6) capable of producing recombinant human-like collagen and target host protein (65KD host cell protein) by fermentation based on a previous-stage vector, genetic engineering strain construction (the Pichia pastoris host strain transformed by the vector is GS115) and a fermentation test experiment. The amino acid sequence of the recombinant human-like collagen is shown in figure 1.
The strain Pichia pastoris-col3-6 has been deposited in China general microbiological culture Collection center (CGMCC, address No. 3 Xilu No. 1 Beijing Kogyo Beichen province), with the deposit number of CGMCC No.20458, and is classified and named as Pichia pastoris, at 7.31.2020.
(II) fermentation and protein purification
The invention carries out induction expression of recombinant human-like collagen in the fermentation culture process of strains, and obtains fermentation liquor through centrifugation, collection and centrifugation of supernatant, filtration sterilization, ultrafiltration desalination concentration, ion exchange chromatography, ultrafiltration desalination and freeze-drying to obtain the recombinant human-like collagen and target host protein, and the specific steps are as follows:
1) Culturing and inducing the strain Pichia pastoris-col3-6, taking out, centrifuging the fermentation liquid with large capacity refrigerated centrifuge to remove thallus, and collecting supernatant;
wherein, the conditions of culturing and induced expression are as follows: taking an inorganic salt BSM culture medium as a bottom material, fermenting the bottom material by using a 10L fermentation tank (the pH is 5.0, the temperature is 29.0 ℃, and the dissolved oxygen is controlled to be about 30 percent), after the glycerol in the bottom material is completely consumed (generally, the wet weight of the thalli reaches 180-210 mg/mL), adding methanol for induction for 40-50 hours, and taking the bottom material out of the tank;
2) filtering the supernatant with 0.22 μm hollow fiber membrane to remove residual thallus and mechanical impurities, and collecting filtrate;
3) ultrafiltering and desalting the filtrate by a 10KD ultrafiltration membrane until the conductivity is lower than 1ms/cm, concentrating the volume to about 0.5L to obtain a concentrated solution, circularly recovering the residual protein of the ultrafiltration system by 300mL of purified water to obtain a recovered solution, fully mixing the concentrated solution and the recovered solution, and adjusting the pH value of the mixed solution to 6.4 by using a dilute sodium hydroxide solution to serve as an ion exchange chromatography stock solution for later use;
4) and (3) carrying out ion exchange chromatography purification on the stock solution (the ion exchange column is filled with CM Sepharose FF): adjusting pH of the ion exchange chromatography stock solution to 6.4 with buffer pair (disodium hydrogen phosphate and sodium dihydrogen phosphate) in 10mmol/L phosphate buffer solution with pH of 6.4 as loading solution, eluting with 10 column volumes of eluent with pH of 6.4 (specifically 10mmol/L phosphate buffer solution containing 0.06mol/L sodium chloride and pH of 6.4), collecting eluate as target host protein, eluting with 10 column volumes of eluent with pH of 6.4 (specifically 10mmol/L phosphate buffer solution containing 0.08mol/L sodium chloride and pH of 6.4), eluting with 10 column volumes of eluent with pH of 6.4 (specifically 10mmol/L phosphate buffer solution containing 0.3mol/L sodium chloride and pH of 6.4), and collecting eluate as recombinant human collagen solution;
5) Respectively carrying out ultrafiltration desalination and concentration on the recombinant human-like collagen solution and the target host protein solution which are collected by ion exchange chromatography by using an ultrafiltration membrane with the density of 10 KD;
6) respectively carrying out vacuum freeze drying on the concentrated solution obtained in the step 5) to obtain the recombinant human-like collagen (figure 2, 115KD) and the target host protein (figure 2, 65 KD).
Through detection, the recovery rate of the recombinant human-like collagen obtained by purification reaches more than 70%, the purity reaches more than 95%, the recovery rate of the target host protein reaches more than 70%, and the purity reaches more than 95%. The protein concentration after purification is determined by a biuret method, and the result shows that the expression quantity of the recombinant human-like collagen of the strain Pichia pastoris-col3-6 can reach 4.8g/L, and although the expression quantity of the target host protein is lower than that of the recombinant human-like collagen, the expression quantity of the target host protein is improved by 1g/L compared with the GS115 fermentation product.
In a word, compared with the existing purification method, the method has the advantages of low cost and simple process, and the obtained pure protein is completely decolorized and is suitable for industrial large-scale production.
Claims (5)
1. A method for purifying protein of pichia pastoris fermentation liquor is characterized by comprising the following steps: the protein purification method comprises the following steps:
Separating and removing thallus cells in the pichia pastoris fermentation liquor, then carrying out ultrafiltration, and carrying out ion exchange chromatography on an ultrafiltration product to respectively obtain recombinant human-like collagen and host cell protein which are generated by pichia pastoris fermentation;
the protein purification method specifically comprises the following steps:
1) centrifuging the pichia pastoris fermentation liquor, filtering and sterilizing supernatant obtained by centrifuging, performing ultrafiltration desalination, and mixing concentrated solution containing recombinant human collagen obtained by ultrafiltration desalination with residual protein recovery solution of an ultrafiltration system containing host cell protein to obtain mixed feed liquid;
2) separating the recombinant human-like collagen and the host cell protein in the mixed feed liquid by ion exchange chromatography;
the step 2) specifically comprises the following steps: adjusting the pH value of the mixed feed liquid to 6.0-6.5 by using sodium hydroxide to obtain an ion exchange chromatography stock solution, and adjusting the pH value of the ion exchange chromatography stock solution to 6.0-6.5 by using disodium hydrogen phosphate and sodium dihydrogen phosphate to carry out sample loading; after the sample loading is finished, eluting host cell protein by using a phosphate buffer solution with the pH value of 6.0-6.5 and the concentration of 8-10 mmol/L of 0.04-0.06 mol/L NaCl as an eluent, eluting by using a phosphate buffer solution with the pH value of 6.0-6.5 and the concentration of 8-10 mmol/L of 0.08-0.1 mol/L of NaCl as an impurity washing solution, and eluting the recombinant human-like collagen by using a phosphate buffer solution with the pH value of 6.0-6.5 and the concentration of 8-10 mmol/L of 0.3-0.4 mol/L of NaCl as an eluent;
The ion exchange column packing adopted by the ion exchange chromatography is selected from weak cation exchangers;
the Pichia pastoris is a Pichia pastoris (Pichia pastoris) strain Pichia pastoris-col3-6, and the preservation number is CGMCC No. 20458.
2. The method for purifying protein of pichia pastoris fermentation broth according to claim 1, wherein: the protein components of the fermentation liquor of the strain comprise 91.3KD of recombinant human-like collagen and 65KD of host cell protein.
3. The method for purifying protein of pichia pastoris fermentation broth according to claim 1, wherein: the preparation method of the pichia pastoris fermentation liquor comprises the following steps: culturing pichia in a fermentation culture medium and carrying out induced expression of the recombinant human-like collagen to obtain pichia fermentation liquor.
4. The method for purifying protein of pichia pastoris fermentation broth according to claim 1, wherein: and the ultrafiltration desalination adopts a 6-15 KD ultrafiltration membrane, and the conductivity of the concentrated solution is lower than 1 ms/cm.
5. The method for purifying protein of pichia pastoris fermentation broth according to claim 1, wherein: the protein purification method further comprises the following steps: after the step 2), respectively carrying out ultrafiltration and desalination on the recombinant human-like collagen solution and the host cell protein solution, and then carrying out vacuum freeze drying to obtain the recombinant human-like collagen and the host cell protein.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011630131.XA CN112724242B (en) | 2020-12-30 | 2020-12-30 | Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011630131.XA CN112724242B (en) | 2020-12-30 | 2020-12-30 | Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112724242A CN112724242A (en) | 2021-04-30 |
| CN112724242B true CN112724242B (en) | 2022-05-24 |
Family
ID=75608324
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011630131.XA Active CN112724242B (en) | 2020-12-30 | 2020-12-30 | Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112724242B (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN113789358B (en) * | 2021-08-28 | 2023-05-12 | 西安德诺海思医疗科技有限公司 | Fermentation process for improving production level of recombinant collagen |
| CN114106202B (en) * | 2021-11-25 | 2023-10-27 | 西安德诺海思医疗科技有限公司 | Conus toxin and collagen fusion protein and preparation method and application thereof |
| CN114163517A (en) * | 2021-12-20 | 2022-03-11 | 西安德诺海思医疗科技有限公司 | Recombinant humanized collagen and purification and endotoxin removal method thereof |
| CN116535494B (en) * | 2023-07-03 | 2023-09-12 | 江苏耀海生物制药有限公司 | Recombinant humanized III type collagen and application thereof |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102020712B (en) * | 2010-11-11 | 2013-05-29 | 北京东方红航天生物技术股份有限公司 | Human-like collagen for vaccine stabilizing agent and production method thereof |
| CN102146426B (en) * | 2010-12-23 | 2013-04-24 | 陕西九州生物医药科技园发展有限公司 | Method for producing recombinant human-like collagen by expression by Pichia pastoris |
| CN106191181B (en) * | 2016-07-22 | 2019-12-13 | 江苏江山聚源生物技术有限公司 | Fermentation process for expressing recombinant protein by pichia pastoris |
| CN107298719A (en) * | 2017-08-17 | 2017-10-27 | 天德悦（北京）生物科技有限责任公司 | Pre-dyed luminescent protein marker preparation method |
-
2020
- 2020-12-30 CN CN202011630131.XA patent/CN112724242B/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| CN112724242A (en) | 2021-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112724242B (en) | Method for producing recombinant human-like collagen and host cell protein by using pichia pastoris | |
| US11788110B2 (en) | Method for enzymatic preparation of glutathione | |
| CN108070032B (en) | Purification method of recombinant human collagen | |
| CN112745385B (en) | Recombinant humanized collagen, industrial preparation method and product application thereof | |
| EP0694616A2 (en) | Process for the preparation of hyaluronic acid by fermentation with streptococcus | |
| CN107353338B (en) | Method for separating pigment molecules in hirudin fermentation liquor | |
| CN108285913B (en) | Process for preparing and extracting L-glutamine | |
| CN116333097A (en) | High-activity recombinant human fibronectin and preparation method and application thereof | |
| CN118085023B (en) | Preparation method of short peptide | |
| CN112778149A (en) | Method for extracting and separating beta-alanine from fermentation liquor | |
| CN111777680B (en) | Separation and purification process for improving stability of recombinant collagen solution | |
| CN117700530A (en) | Purification production method of recombinant IV-type humanized collagen containing dopa | |
| CN104387459A (en) | Industrial separation and purification method of bacterial source antibacterial peptide | |
| US11639515B2 (en) | Genetically engineered strain for producing porcine myoglobin and food-grade fermentation and purification thereof | |
| CN102277371A (en) | Method for preparing BNP (brain natriuretic peptide) | |
| CN102660568B (en) | A method for preparing recombinant thymulin alpha 1 | |
| CN112813115A (en) | Production process of high-purity L-arginine | |
| CN112209999B (en) | Method for quickly separating pigment in recombinant epidermal growth factor fermentation liquor | |
| CN113999271B (en) | Simple method for extracting 5' -cytidylic acid from microbial fermentation broth | |
| CN117466992B (en) | Fibronectin mutant and preparation and application thereof | |
| CN117886923B (en) | Recombinant humanized collagen and encoding gene and application thereof | |
| CN109055464B (en) | Culture medium for producing recombinant human brain natriuretic peptide and fermentation process | |
| CN117106844A (en) | Method for synthesizing phenoxyacetamido penicillin potassium salt by fermentation method | |
| CN116041223A (en) | Method for extracting L-citrulline by utilizing ion exchange method | |
| CN116854798A (en) | Pichia pastoris fermentation expression recombinant type III mussel mucin and purification method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |